Paper · 20008019
Secretion and dipeptidyl peptidase-4-mediated metabolism of incretin hormones after a mixed meal or glucose ingestion in obese compared to lean, nondiabetic men.
Carr RD and 7 others. J Clin Endocrinol Metab, 2010. Cited by 121 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Secretion and dipeptidyl peptidase-4-mediated metabolism of incretin hormones after a mixed meal or glucose ingestion in obese compared to lean, nondiabetic men. Papers, record 20008019. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20008019
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Secretion and dipeptidyl peptidase-4-mediated metabolism of incretin hormones after a mixed meal or glucose ingestion in obese compared to lean, nondiabetic men.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Dipeptidyl Peptidase 4 | Major topic |
| Gastric Inhibitory Polypeptide | Major topic |
| Glucagon-Like Peptide 1 | Major topic |
| Glucose | Major topic |
| Obesity | Major topic |
| Thinness | Major topic |
| Acetaminophen | |
| Adult | |
| Area Under Curve | |
| Food | |
| Humans | |
| Insulin Resistance | |
| Male | |
| Young Adult |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT05987748 | The Clock Thickens: Morning or Evening Training for the Treatment of NAFLD? | Background |
Source ClinicalTrials.gov
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by70
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 121 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,449,760 | Do Fasting GLP-1 and GIP Levels Predict the Initial Pharmacological Response to Semaglutide and Tirzepatide? | Diagnostics (Basel) | 2026 | https://conductscience.org/library/papers/42449760 | PubMed |
| 41,746,476 | The Gut-Brain Axis in Obesity: Mechanisms, Development, and Therapeutic Perspectives. | Curr Nutr Rep | 2026 | https://conductscience.org/library/papers/41746476 | PubMed |
| 41,575,482 | Gut Peptide Alterations in Type 2 Diabetes and Obesity: A Narrative Review. | Curr Obes Rep | 2026 | https://conductscience.org/library/papers/41575482 | PubMed |
| 41,410,534 | Metabolic and hormonal effects of whole grains of rye, oats and wheat in dog food. | J Anim Sci | 2026 | https://conductscience.org/library/papers/41410534 | PubMed |
| 41,408,640 | Preliminary evaluation of oxyntomodulin as a biomarker for metabolic risk stratification in adults with obesity. | J Transl Med | 2025 | https://conductscience.org/library/papers/41408640 | PubMed |
| 39,583,750 | Caveolae with serotonin and NMDA receptors as promising targets for the treatment of Alzheimer's disease. | Int J Physiol Pathophysiol Pharmacol | 2024 | https://conductscience.org/library/papers/39583750 | PubMed |
| 39,203,005 | Caveolae with GLP-1 and NMDA Receptors as Crossfire Points for the Innovative Treatment of Cognitive Dysfunction Associated with Neurodegenerative Diseases. | Molecules | 2024 | https://conductscience.org/library/papers/39203005 | PubMed |
| 39,138,690 | Elevations in plasma glucagon are associated with reduced insulin clearance after ingestion of a mixed-macronutrient meal in people with and without type 2 diabetes. | Diabetologia | 2024 | https://conductscience.org/library/papers/39138690 | PubMed |
| 38,490,484 | Fasting and post prandial pancreatic and enteroendocrine hormone levels in obese and non-obese participants. | Peptides | 2024 | https://conductscience.org/library/papers/38490484 | PubMed |
| 38,351,071 | The Role of G Protein-Coupled Receptors and Receptor Kinases in Pancreatic β-Cell Function and Diabetes. | Pharmacol Rev | 2024 | https://conductscience.org/library/papers/38351071 | PubMed |
1 to 10 of 70
See all 70 cited byGenes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| DPP4 | 1,803 | PubTator's text mining | https://conductscience.org/library/genes/1803 | NCBI Gene |
| GCG | 2,641 | PubTator's text mining | https://conductscience.org/library/genes/2641 | NCBI Gene |
| GIP | 2,695 | PubTator's text mining | https://conductscience.org/library/genes/2695 | NCBI Gene |
| IGLP1 | 7,925 | PubTator's text mining | https://conductscience.org/library/genes/7925 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20008019
GET https://conductscience.org/api/papers/v1/20008019/cited_by?page=2